𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Splenic granulomas in a patient with severe Crohn's disease associated with multiple extraintestinal manifestations

✍ Scribed by Lucia Castellani; Alessandro Sartini; Margherita Marocchi; Tiziana Balbi; Andrea Belluzzi


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
340 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Splenic tuberculosis in a patient with C
✍ Maria Cappello; Claudia Randazzo; Giulia Rizzuto; Celestino Bonura; Gaetano Di V πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 1 views

FIGURE 1. MRI of the spleen. a: T1-weighted image on dynamic contrast-enhancement (axial). b: T1-weighted image on dynamic contrast-enhancement (coronal).

Severe pulmonary disease in association
✍ Lea Bentur; Jesse Lachter; Ilana Koren; Ofer Ben-Izhak; Alexandra Lavy; Yedidia πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 2 views

Pulmonary manifestations of Crohn's disease are infrequent in adults and even less common in children. Our literature search found only a few cases of Crohn's disease causing pulmonary manifestations in children. We report on the case of a 13-year-old girl in whom severe pulmonary disease was found

Severe Legionella pneumophila pneumonia
✍ Florian Beigel; Matthias JΓΌrgens; Levent Filik; Lutz Bader; Christian LΓΌck; Burk πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 1 views

## Background: Immunosuppressive therapy with anti-tnf-alpha antibodies is effective in patients with inflammatory bowel disease (ibd). however, there is an increased risk for infections associated with this therapy. ## Methods: Here, we report the case of a 58-year-old patient with crohn's disea

Treatment-associated acute myeloid leuke
✍ Koushik K. Das; Ha Thanh Nishino; Andrew T. Chan πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 1 views

To the Editor: Immunomodulatory therapies such as 6-mercaptopurine (6-MP) and azathioprine provide high remission rates and success in avoiding steroid dependence in patients with inflammatory bowel disease (IBD). However, these treatments are not without adverse effects including leukopenia, liver